Exactly. Does anyone know how expensive a phase 3
Post# of 157748
Cyrus is confident we will start a trial next year for NASH. I mean people are always willing to invest here but I believe we are tapped out and will seek out money for a partnership. Maybe our past CRO will pay out but I don’t see them paying 100s of millions. Although they should.
Nobody should be surprised by this type of announcement is made. The funny part is people will be. That’s fine buy back in above a dollar.
This year has been rough but I look forward to 2023.


CytoDyn Inc (CYDY) Stock Research Links
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
https://firegatebiotech.com/2025
https://zenodo.org/records/17291133?token=eyJ...kN7msthgMA
— Jeremiah 51:36